PRESS RELEASE published on 07/01/2025 at 17:30, 1 year 1 month ago Sartorius completes acquisition of MatTek Sartorius completes acquisition of MatTek from BICO Group AB, expanding its cell technology portfolio and creating synergies with existing solutions for drug development Acquisition Sartorius Drug Development MatTek Cell Technology
BRIEF published on 05/02/2025 at 09:27, 1 year 3 months ago Sartorius prolonge le mandat d'Alexandra Gatzemeyer au conseil d'administration Sartorius AG Industrie Biopharmaceutique Conseil Exécutif Alexandra Gatzemeyer Produits De Laboratoire
BRIEF published on 05/02/2025 at 09:27, 1 year 3 months ago Sartorius Extends Executive Board Tenure for Alexandra Gatzemeyer Executive Board Sartorius AG Biopharmaceutical Industry Alexandra Gatzemeyer Lab Products
PRESS RELEASE published on 05/02/2025 at 09:22, 1 year 3 months ago Sartorius Supervisory Board extends appointment of board member Alexandra Gatzemeyer Sartorius AG extends Dr. Alexandra Gatzemeyer's Executive Board appointment until 2031, responsible for Lab Products & Services Division Executive Board Sartorius AG Appointment Extension Alexandra Gatzemeyer Lab Products & Services Division
BRIEF published on 04/16/2025 at 07:04, 1 year 3 months ago Sartorius annonce un bon début de premier trimestre 2025 Croissance Des Ventes Sartorius AG Marge D'EBITDA Premier Trimestre 2025 Solutions De Bioprocédés
BRIEF published on 04/16/2025 at 07:04, 1 year 3 months ago Sartorius Reports Strong Start in 2025 First Quarter EBITDA Margin Sales Growth Sartorius AG First Quarter 2025 Bioprocess Solutions
PRESS RELEASE published on 04/16/2025 at 06:59, 1 year 3 months ago Strong start to the year: Sartorius achieves significant profitable growth in the first quarter Sartorius AG achieves significant profitable growth in the first quarter of 2025 with a 6.5% increase in group sales revenue and a strong start in consumables business Profitable Growth Sales Revenue Sartorius AG First Quarter Consumables Business
BRIEF published on 04/04/2025 at 18:05, 1 year 4 months ago Sartorius to Acquire MatTek from BICO AB Drug Development Regulatory Approval Mergers & Acquisitions 3D Microtissue Models Cell Culture
BRIEF published on 04/04/2025 at 18:05, 1 year 4 months ago Sartorius va acquérir MatTek auprès de BICO AB Fusions Et Acquisitions Développement De Médicaments Approbation Réglementaire Culture Cellulaire Modèles De Microtissus 3D
PRESS RELEASE published on 04/04/2025 at 18:00, 1 year 4 months ago Sartorius to acquire microtissue business MatTek from Swedish BICO AB Sartorius to acquire microtissue business MatTek from Swedish BICO AB, advancing cell culture portfolio with 3D models and primary cells for drug development. Acquisition expands Lab Products & Services division Acquisition Sartorius Microtissue MatTek BICO AB
Published on 08/14/2026 at 13:30, 1 hour 20 minutes ago Digi Power X Reports Second Quarter 2026 Financial Results and Provides Operational Update and 2027 Outlook
Published on 08/14/2026 at 13:15, 1 hour 35 minutes ago Mako Mining Reports Q2 2026 Financial Results, Including Adjusted EBITDA(1) of US$31.7 Million and EPS of US$0.16/Share
Published on 08/14/2026 at 13:10, 1 hour 40 minutes ago SouthGobi Announces Second Quarter 2026 Unaudited Financial and Operating Results
Published on 08/14/2026 at 09:01, 5 hours 49 minutes ago Apex Announces Filing of Final Base Shelf Prospectus
Published on 08/14/2026 at 08:00, 6 hours 50 minutes ago Touchstone Exploration Announces Second Quarter 2026 Results and Operational Update
Published on 08/14/2026 at 14:35, 15 minutes ago Bitmine Immersion Technologies Announces Record and Payment Dates for Cash Dividends on 9.50% Series A Perpetual Preferred Stock
Published on 08/14/2026 at 13:31, 1 hour 19 minutes ago Diginex Limited Announces Extraordinary General Meeting to Approve Proposed Acquisition of Resulticks
Published on 08/14/2026 at 13:20, 1 hour 30 minutes ago Nagarro Management Board and Supervisory Board recommend the acceptance of the voluntary public takeover offer by Persistent
Published on 08/13/2026 at 18:00, 20 hours 50 minutes ago Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 2 days 21 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 2 days 21 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 3 days 20 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 3 days 20 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
